Axinn partner Chad Landmon's article "2012 Court Decisions Impact the Life Science Industry" was published by Pharmaceutical Compliance Monitor. In the article, Chad addresses how FDA and FTC regulations in 2012 will affect the stem cell industry, the promotion of drug products and the structure of future patent settlements. 

Click here to access the article.